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Pheromone-stimulated yeast cells and haploid gpal
deletion mutants arrest their cell cycle in G1.
Overexpression of a novel gene called MSG5 suppresses
this inhibition of cell division. Loss of MSG5 function
leads to a diminished adaptive response to pheromone.
Genetic analysis indicates that MSG5 acts at a stage
where the protein kinases STE7 and FUS3 function to
transmit the pheromone-induced signal. Since loss of
MSG5 function causes an increase in FUS3 enzyme
activity but not STE7 activity, we propose that MSG5
impinges on the pathway at FUS3. Sequence analysis
suggests that MSG5 encodes a protein tyrosine
phosphatase. This is supported by the fimding that
recombinant MSG5 has phosphatase activity in vitro and
is able to inactivate autophosphorylated FUS3. Thus
MSG5 might stimulate recovery from pheromone by
regulating the phosphorylation state of FUS3.
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Introduction
The yeast Saccharomyces cerevisiae has two haploid cell
types, a and a, which can mate to form the a/a diploid.
The mating reaction is initiated by peptide pheromones
secreted by each haploid cell type. ca cells secrete the
pheromone a-factor which acts on a cells, and a cells secrete
a-factor which acts on a cells. Pheromones binding to
specific receptors on target cells activate a signaling pathway,
ultimately leading to transcriptional changes, alteration of
cellular morphology ('shmoo' formation) and arrest of
mitotic cell division in G1. However, the mating pheromone
response is transient because cells adapt to the continued
presence of pheromone and resume the mitotic cycle (for
review, see Marsh et al., 1991).
Genetic analysis of the pheromone response pathway has
led to the identification of many components required for
signal transduction. The S7E2 and STE3 genes encode the
receptors for at-factor and a-factor, respectively, and their
primary structures are predicted to contain seven
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transmembrane domains, a characteristic of mammalian G
protein-coupled receptors (Burkholder and Hartwell, 1985;
Nakayama et al., 1985; Hagen et al., 1986). GPAI, STE4
and STEM8 encode the a, i3 and "y subunits of a G protein
that is thought to be functionally coupled to the pheromone
receptor (Dietzel and Kurjan, 1987; Miyajima et al., 1987;
Jahng et al., 1988; Blinder et al., 1989; Whiteway et al.,
1989). In the current model for signal transmission,
pheromone binding to the receptor promotes the exchange
of GDP for GTP, resulting in dissociation of the Gj3y
complex from the GTP-bound Ga subunit. Free G(3y
complex then propagates the signal by an unknown
mechanism involving STE5 to a group of protein kinases
encoded by the STE20, STE7, STE]], FUS3 and KSSJ genes
(Leberer et al., 1993; for review, see Marsh et al., 1991).
The pheromone response pathway kinases are thought to
function in the order STEl 1, STE7, FUS3/KSS1 (Caims
et al., 1992; Gartner et al., 1992; Stevenson et al., 1992;
Errede et al., 1993; Zhou et al., 1993). Both FUS3 and
KSS1 belong to the mitogen-activated protein (MAP) kinase
family, which plays a key role in a variety of signal
transduction pathways (Courchesne et al., 1989; Elion et al.,
1990, 1991). STE7 is most closely related to the MAP kinase
activator (Crews et al., 1992) and is able to phosphorylate
and activate FUS3 in vitro (Errede et al., 1993).
Ultimately, activation of the MAP kinase family members
leads to transcriptional activation of mating-specific genes
and to cell cycle arrest. The transcriptional effects are
mediated by the STE12 transcription factor (Dolan et al.,
1989; Errede and Ammerer, 1989). Cell cycle arrest by
mating pheromone appears to occur by inactivation of three
functionally redundant GI-specific cyclins (CLN1, CLN2
and CLN3) required for G1 function of the CDC28 protein
kinase (Wittenberg et al., 1990). One of the physiological
targets of FUS3 is FAR1, which is a pheromone-inducible
phosphoprotein that mediates inactivation of CLN2 and
CLN1 (Chang and Herskowitz, 1990; Peter et al., 1993;
Valdiviesso et al., 1993).
The responsiveness of a signal transduction system to a
persistent stimulus diminishes with time. This phenomenon,
known as desensitization or adaptation, is a universal
characteristic of signal response systems. Several molecular
mechanisms for desensitization have been described in the
pheromone response pathway. Mutations in the SST2 gene
confer defects in adaptation and increased pheromone
sensitivity (Chan and Otte, 1982), indicating that SST2 is
required for adaptation to pheromone although its function
is unknown. The hyperactivating mutation GPAJv,I50,
which is analogous to the oncogenic rasvall2 mutation, has
a dominant hyperadaptive phenotype and is capable of
suppressing the adaptation defect of sst2 mutants (Miyajima
et al., 1989). Thus it is thought that the activated GU subunit
stimulates an adaptive response antagonistic to the signal
generated by the G(3'y complex. Additionally, GPA1 and
SST2 lie on different adaptive pathways.
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To elucidate further the components operating in the
adaptive response, we isolated genes which when
overexpressed from multicopy plasmids are capable of
suppressing the lethality of gpal - mutants, which is due to
the constitutive activity of the free Go3y subunits. We
anticipated that overexpression of components downstream
of GPAl in the adaptation pathway would stimulate recovery
from growth arrest. One such gene, which we have named
MSG5, is described here. It encodes a putative protein
tyrosine phosphatase. We analyzed the phenotypes resulting
from overexpression and disruption of MSG5 with respect
to pheromone response. In addition, we deduced the point
at which MSG5 functions in the pheromone response
pathway. Based on these results, we discuss the possible role
of the MSG5 protein in the recovery pathway.
Results
Isolation of high copy number plasmids which
suppress the gpa 1- mutation
We isolated high copy number plasmids containing
S. cerevisiae genomic DNA, that allowed gpal- cells to
grow under restrictive conditions. For this purpose, a yeast
strain (KMG59) with a chromosomal deletion of the GPAI
gene was constructed that contained the GPAI gene under
the control of the GALI promoter on a plasmid (pG1501).
As a functional GPAJ gene is required for haploid cell
growth, this strain grows in medium containing galactose,
where the GAL] promoter is induced. In medium containing
glucose, the GALI promoter is repressed. Under these
conditions, GPA1 is depleted and the cells arrest in the GI
phase of the cell cycle (Miyajima et al., 1987).
The conditional gpal- strain (KMG59 pG1501) was
transformed with a yeast genomic library constructed in the
multiple copy vector YEp213, which contains the yeast
LEU2 gene for selection. Leu+ transformants were
screened by plating directly on glucose-based medium to
select for suppression of the gpal- phenotype. Eight
colonies were dependent on a library plasmid for their ability
to grow on glucose. Each isolate grew on glucose-based
medium even upon loss of the GALI- GPAI plasmid
(pG1501). The latter result excludes the possibility that any
of the genes suppressed the gpal- phenotype by allowing
the GAL] promoter to work in the presence of glucose. The
suppressing plasmids were recovered in Escherichia coli and
shown to rescue the gpal- phenotype when reintroduced
into KMG59 cells. The DNAs from these plasmids could
be grouped into five classes by restriction analysis. We
named these genes MSG for multicopy suppressor ofgpal,
and the MSG5 gene was characterized in this study.
Effect of MSG5 on mating pheromone signal
transduction
The ability of MSG5-overexpressing cells to respond to
mating pheromone was studied. Mating pheromone induces
transcription of mating-specific genes and causes GI arrest.
One test for normal transcriptional induction is the level of
STE12-dependent transcription. When analyzed using a
reporter plasmid (pUZ4) carrying a pheromone-inducible
lacZ gene, MSG5 overexpression caused - 50% inhibition
of the c-factor-inducible j-galactosidase activity (Table I).
Halo bioassays were performed to examine the growth arrest
response to pheromone induction. Wild-type cells containing
MSG5 on a high copy number plasmid recovered more
quickly from pheromone-induced growth arrest than did cells
with the control plasmid (Figure IA). To examine further
the recovery promoted by MSG5 overexpression,
experiments were performed in an sst2 mutant background.
The SS12 gene product is involved in recovery from
pheromone-induced arrest and sst2 mutants are more
sensitive to pheromone than wild-type cells (Chan and Otte,
1982). AL4Ta sst2 cells transformed with YEpMSG5
displayed an apparent sensitivity to pheromone quantitatively
similar to the same cells transformed with the control plasmid
(YEp 13). However, the halos produced with MSG5-over-
expressing lawns subsequently became turbid and eventually
filled in (Figure 1B). Thus, MSG5 overexpression caused
cells to overcome pheromone-induced arrest and resume
growth, suggesting that MSG5 is a component of the
recovery pathway.
Because overexpression ofMSG5 dramatically promoted
resuming growth of pheromone-arrested cells, we tested the
effect of a MSG5 disruption on cell growth and pheromone
response. The chromosomal MSG5 gene of a wild-type
diploid strain 15D (leu211eu2) was transplaced by a DNA
fragment containing MSG5 with a LEU2 selectable marker
inserted within part of the coding region (Figure 2). Upon
sporulation and tetrad dissection, all four spores were viable
Table I. Effect of MSG5 on transcription from a pheromone-inducible promoter
Strain Plasmid (3-galactosidase activity
- a-factor + a-factor Glucose Galactose
KMG604C YEpl3 3.1 45.6 - -
YEpMSG5 2.4 26.6 - -
KMG60-3D YEpl3 28.4 67.1 - -
YEpMSG5 8.7 38.0 - -
l5Dau-GS YEpl3 0.6 23.6 0.6 53.8
YEpMSG5 0.9 9.3 0.5 55.2
KMG60-4C (MATa STEII+) and KMG60-3D (AMTa STEI-4) contained the reporter plasmid pUZ4. Cells were grown in synthetic medium
containing the appropriate amino acids and 2% glucose, and were induced with 2 ug/ml a-factor for 3 h. l5Dau-GS (MA4Ta) contained plasmids
pGS3 (pGAL-STE12) and pUZ4. Cells were grown in synthetic medium containing the appropriate amino acids and 2% glucose, and were induced
with 2 ug/ml a-factor for 3 h. For induction of STE12 cells were shifted from sucrose medium to glucose or galactose medium, and were grown for
an additional 6 h. The units shown are the average of two or three experiments in which two independent Leu+ plasmid-bearing transformants were
assayed.
62
Tyrosine phosphatase in yeast signal transduction
and msg5-1::LEU2 spore clones exhibited no obvious growth
defect compared with isogenic wild-type spore clones.
Therefore, MSGS is not required for vegetative growth.
MA Ta msgS-1::LEU2 strains were slightly more sensitive
to a-factor-induced cell cycle arrest than isogenic wild-type
strains by halo bioassays (data not shown). An MSG5
deletion mutation in which 71 % of coding sequence is
replaced by the LEU2 gene (msg5A-2::LEU2) was also
constructed and tested (Figure 2). This deletion mutation has
the same phenotype as the disruption allele (msg5-1::LEU2).
Compared with the pheromone sensitivity of sst2- cells,
that of msg5- cells is much weaker. The minimal effect of
msg5 on the pheromone sensitivity may reflect the presence
of a functionally redundant gene or other mechanisms of
adaptation may remain available to msg5- cells.
A GPAlv5o mutation causes hyperadaptation to a-factor
(Miyajima et al., 1989). This mutation is believed to increase
the activity of the Ga subunit by decreasing its intrinsic
GTPase activity. Thus GPAJ appears to play a positive role
in the transduction of signals which stimulate recovery from
pheromone-induced growth arrest. If MSG5 is a target for
this GPA1 signal, loss of the MSGS (msgS-1::LEU2) should
block the ability of GPAJVal5o to promote recovery. Since
GPAJval5o is dominant with respect to GPA1 + for




carrying GPAJval5o was transformed into MATa wild-type
and msg5-1::LEU2 strains and the ability of cells to respond
to mating pheromone was assayed (Figure IC). As observed
previously (Miyajima et al., 1989), GPAJval5O in wild-type
cells markedly accelerated recovery from pheromone
response. In contrast, GPAlval5o was unable to promote
adaptation in msgS-1::LEU2 cells. These results suggest that
MSG5 functions downstream of GPA1 in the pathway and
that MSG5 is a potential transducer of the Ga subunit signal.
MSG5 shares homology with the active site of
protein tyrosine phosphatases
Plasmid YEpMSG5 causes three distinct phenotypes:
suppression of gpal- deletion, promotion of recovery from
pheromone-induced growth arrest and a decrease in
transcription of pheromone response genes activated by ca-
factor. Subcloning experiments showed that a single segment
(2 kb Hindm) of YEpMSG5 was responsible for all three
phenotypes (Figure 2), suggesting that overexpression of a
single gene (MSG5) promotes these activities. The nucleotide
sequence of this essential region and surrounding regions
was determined. Sequence analysis of the MSG5 gene
revealed an open reading frame (ORF) of 489 amino acid
residues (Figure 3). This size is consistent with the length
-it
Fig. 1. Response to a-factor. Cells were plated on soft agar. Sterile filter disks were placed on the nascent lawn and samples of synthesized a-factor
(Sigma) were pipetted onto the disks. Plates were incubated at 30°C for 2 days. The amount of a-factor added to each disk was: (A and C) 1.6 lAg
(left) and 8 Ag (right); (B) 0.32 ug (top), 1.6 ltg (left) and 8 jAg (right); (A) 15Dau (wild-type) with YEplacl8l (left) or YEplacMSG5 (right);







Fig. 2. Restriction map and disruption of MSG5. The top line
represents an abbreviated restriction map of the MSG5 region. The
arrow represents the ORF and direction of transcription of MSG5 (see
Figure 6). Restriction sites: Ba, Ball; Bg, BgEl; E, EcoRI; H,

















































Fig. 3. Predicted amino acid sequence of the MSG5 gene product.
Nucleotide sequence was determined as described in Materials and


























Fig. 4. Amino acid sequence alignment of MSG5, PAC-1, CL100,
VHR, YVH1 and VHI. The conserved amino acid residues are boxed.
Asterisks indicate the residues that are completely identical and they
are shaded. Dashes are inserted to allow for maximal alignment of the
sequences.
of the transcript (- 1.8 kb) identified by hybridization
analysis of total RNA (see Figure 6).
The predicted protein sequence was compared with those
in the protein structural motif database Prosite (Bairoch,
1991). The search revealed that the MSG5 polypeptide
contains a sequence related to an 'HC motif (Ile/Val-His-
CysXXXXXArg) that comprises the conserved active site
of protein tyrosine phosphatases (PTPases) (Fisher et al.,
1991). The C-terminal portion of the MSG5 protein has
significant amino acid sequence similarity to a phosphatase
encoded by the late H1 gene of vaccinia virus (VH 1), which
is able to dephosphorylate protein substrates modified on both
tyrosine and serine residues (Figure 4) (Guan et al., 1991).
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Fig. 5. Phosphatase activity. GST-MSG5 (0), GST-MSG5Ala3l9
(O) and GST (A) were expressed in bacteria and purified in parallel
by using glutathione-Sepharose CL-4B. Dephosphorylation of pNPP,
expressed as increased absorbance at 410 nm, was measured as a
function of protein concentration. The GST-MSG5 fusion protein was
also incubated in the presence of 1 mM sodium vanadate (0).
Members of a family of PTPases with similarity to VH1 are
now expanding and include a growth factor-inducible gene
in murine 3T3 cells (3CH134) (Charles et al., 1992) and
its human homolog (CLIOO) (Keyse and Emslie, 1992), a
mitogen-inducible gene in human T cells (PAC-J) (Rohan
et al., 1993), the VH1-related proteins in human fibroblasts
(VHR) and yeast (YVH1) (Guan et al., 1992; Ishibashi
et al., 1992) (Figure 4). VHR has been shown to be a dual
specificity phosphatase which dephosphorylates both serine
and tyrosine residues in vitro (Ishibashi et al., 1992). This
group of phosphatases most likely represents a new structural
family of PTPases that share regulatory or enzymatic
properties.
To determine whether the MSG5 protein possesses
phosphatase activity, the complete ORF ofMSG5 was cloned
into a bacterial expression vector to generate a fusion gene
encoding a glutathione S-transferase fragment (GST)
followed by MSG5. Soluble GST-MSG5 protein was
readily produced at high levels in bacteria. This fusion
protein was purified by glutathione affinity chromatography.
GST-MSG5 was found to hydrolyze rapidly p-nitrophenyl
phosphate (pNPP), a chromogenic substrate structurally
related to phosphotyrosine (Figure 5). This phosphatase
activity was inhibited by sodium vanadate, a well-known
inhibitor of PTPases.
The cysteine residue in the HC motif is absolutely essential
for phosphatase activity (Streuli et al., 1990; Guan et al.,
1991). To confirm that the cysteine present in the MSG5
HC motif is essential for phosphatase activity, we performed
site-directed in vitro mutagenesis to change the MSG5 codon
for Cys319 to Ala319 (see Materials and methods).
GST-MSG5Ala3l9 was produced in bacteria in an identical
manner to wild-type GST-MSG5 and tested in parallel for
its ability to dephosphorylate pNPP. As expected for a
catalytically inactive derivative, the GST-MSG5la3l9
protein did not hydrolyze pNPP (Figure 5). We also
examined the MSG5A'a3I9 mutation in vivo for its ability to
affect pheromone-induced signal transduction. The
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Fig. 6. Northern analysis of MSG5 transcription. Three micrograms of
total RNA prepared from l5Da (MA Ta), 15D (MATa/MA Ta) and
l5Dau-b (MATa barl-) were run on 1% formaldehyde-agarose gels
and analyzed by Northern blot analysis using MSG5 and FUSI probes.
The same blots were analyzed using a LEU2 probe as a control. To
analyze the MSG5 transcript in cells responding to a-factor, samples
were taken from a culture of l5Dau-b at the indicated times following
addition of a-factor (40 ng/ml). Samples were analyzed for the
proportion of budded cells (top panel) and Northern blot analysis. The
intensity of MSG5 bands was quantitated by densitometric tracing with
a film of a lesser exposure.
MSG5AMa3l9 mutation lost the ability to promote recovery
from pheromone-induced cell cycle arrest even when the
mutated form ofMSG5 was overexpressed under the control
of GALI promoter (data not shown).
Regulation of MSG5 gene expression
Northern analysis with an MSG5 probe revealed a single
major message of - 1.8 kb. This transcript was observed
in haploid cells of both mating types as well as in
MATa/MA Ta diploids (Figure 6). To see whether a-factor
could modulate MSG5 expression, an asynchronous culture
was treated with at-factor and analyzed for the presence of
MSG5 transcripts at the designated intervals over the next
2 h (Figure 6). The top panel shows that asynchronous cells
treated in this way arrested within a single cell cycle as
unbudded G1 cells. The MSG5 transcript increased - 5-fold
in response to mating pheromone treatment. This
accumulation is maximal within 30 min following addition
of oa-factor. Thus the kinetics of this increase appear to be
slower than the transcriptional response of the pheromone-
induced FUSI gene, which reaches its plateau within 15 min
after a-factor addition (McCaffrey et al., 1987).
The increase of the MSG5 transcript in response to a-factor
could be either a direct result of pheromone action or an
indirect affect mediated by synchronization at the G1
Table II. List of strains
Strain Genotype
15D MATaIMA Ta adelladel his21his2 leu2Ileu2 trplltrpl
ura3/ura3
l5Da MA Ta adel his2 leu2 trpl ura3
15Dau MATa adel his2 leu2 trpl ura3
15Dau-b MATa bar] adel his2 leu2 trpl ura3
15Dau-GS MATa adel his2 leu2 trpl ura3 [pGS3 (pGAL-STE12)]
BC180 MATa sst2-A2 ade2 his3 leu2 ura3
DD1-2B MATa adel his2 leu2 trpl ura3
DD1-2D MATa msg5-J::LEU2 adel his2 leu2 trpl ura3
KMG59 MATa gpal::HIS3 his3 leu2 trpl ura3 [pGl501
(pGAL1-GPA1)]
KMG60-3D MATa STEJJ-4 his3 leu2 trpl ura3
KMG60-4C MATa his3 leu2 trpl ura3
interval of the cell cycle. The MSG5 transcript levels were
characterized by Northern blot analysis of total RNA
prepared from samples taken at 20 min intervals after release
from the mating pheromone-induced G1 arrest. The
accumulation of the MSG5 transcript decreased following
removal of a-factor and MSG5 mRNA failed to accumulate
prior to the second cycle of bud emergence corresponding
to the G1 interval (data not shown). These results indicate
that the accumulation of the MSG5 transcript in response
to c-factor is not just the consequence of synchronization
in G1.
We tested whether transcriptional induction of MSG5 is
sufficient for activation of MSG5 in the pheromone response.
To obtain conditional, high level expression of the MSG5
gene in yeast cells, the MSG5 ORF was fused to the GAL]
promoter. In the presence of galactose, wild-type cells
carrying a plasmid with GAL] -MSG5 did not respond to
az-factor for growth arrest and they were mating defective
(data not shown).
Mapping MSG5 function in the pheromone response
pathway
The phenotype of a strain that combines mutations in genes
affecting two different steps in a cellular process can provide
information about the order in which two gene products
function. To learn where MSG5 functions with respect to
other signaling components in the pathway, we examined
the effect ofMSG5 overexpression on constitutive activation
by a hyperactive allele of STE]] (STEJJ-4) (Stevenson et al.,
1992) or by overproduction of the STE12 gene product
(Dolan and Fields, 1990). A plasmid carrying a pheromone-
inducible lacZ gene (pUZ4) was used to monitor
transcriptional activation by measurement of 3-galactosidase
activity. When the reporter plasmid was present in wild-type
MATa cells, a-factor stimulated the production of,-galac-
tosidase by > 10-fold (Table I). Overexpression of MSG5
caused an - 2-fold decrease in expression of lacZ compared
with at-factor stimulated wild-type cells. The STE11-4
mutation or overexpression of the wild-type STE12 gene by
the galactose-inducible GALI led to constitutive transcription
of the reporter gene, as judged by the increased level of ,B-
galactosidase activity in the absence of a-factor (Table I).
Overexpression of MSG5 resulted in a decrease in the
constitutive activity by the STE11-4 mutations, whereas it
did not affect the constitutive level in the case of STE12
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Fig. 7. In vitro FUS3 and STE7 kinase activities. (A) Comparison of
kinase activity for FUS3 isolated from nmsg5- disruption strain
(DD1-2D, A) or MSG5+ strain (DDI-2B, +). Uninduced cultures or
pheromone-induced cultures (4 AM a-factor, 1 h) of these strains were
the source protein extract for FUS3M (wt) or FUS3MArg42 (R42)
immune complexes that are present in reactions as indicated. The
target substrate was an N-terminal fragment of FARI (250 ng) and
was present in all assays. (B) Comparison of kinase activity for STE7
isolated from msg5S disruption strain (DDI-2D, A) or MSG5+ strain
(DD1-2B, +). Pheromone-induced cultures (4 /AM ca-factor, 1 h) of
these strains were the source protein extract for STE7M (wt) or
STE7MArg220 (R220) immune complexes that are present in reactions as
indicated. The target substrate, FUS3MArg42 (250 ng), was present in
all assays.
the signal, these results position the action of MSG5 after
the STEl 1 protein kinase but prior to the STE12 transcription
factor in the pathway.
Three protein kinases, STE7, FUS3 and KSS 1, have been
implicated as components acting between STE 11 and STE12
in the pheromone response pathway (Marsh et al., 1991).
After pheromone treatment, FUS3 and KSS1 rapidly become
phosphorylated at tyrosine and threonine residues. For FUS3
it has been shown that phosphorylation at both residues is
essential for function (Gartner et al., 1992). Because MSG5
has the structural and enzymatic characteristics of protein
tyrosine phosphatases, one attractive hypothesis for its role
in promoting adaptation is that MSG5 dephosphorylates and,
thereby, inactivates FUS3 (and KSS 1).
According to the above hypothesis, loss ofMSG5 function
should enhance FUS3 kinase activity. To test this possibility,
we performed immune complex phosphorylation assays with
a myc epitope tagged version of FUS3 (FUS3M) isolated
from msgS-1::LEU2 disruption cells (DD1-2D) and from
cells that express MSG5 (DD1-2B). We used an N-terminal
fragment of the FARI protein as the FUS3-specific substrate
(Errede et al., 1993; Peter et al., 1993). A stronger signal
for FARI phosphorylation resulted when FUS3M was
isolated from pheromone-induced cells which lack MSG5
than from cells which express MSG5 (Figure 7A, compare
lanes 5 and 6). Although the overall amount of FARI
phosphorylation was less, a similar effect of msg5 disruption
was observed when FUS3M was isolated from uninduced
cells (Figure 7A, lanes 1 and 2). The absence of FARI
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phosphorylation in parallel reactions using the catalytically
inactive FUS3MArg42 substitution derivative confirms that
FUS3M is responsible for the FARI phosphorylation
observed in these assays (Figure 7A, lanes 3, 4, 7 and 8).
Because the FUS3M protein for these experiments was
expressed from the constitutive TPII promoter, its expression
was independent of the genetic background or pheromone-
induced state. Additionally, immune blot analysis confirmed
that the same amount of protein was present in extracts used
for immune complex formation (data not shown). These
results are consistent with FUS3 being in a more active state
when it is isolated from cells that do not express MSG5.
To distinguish whether the effect of the msgS disruption
is specific for FUS3 or might generally affect kinase
activities, we performed analogous immune complex
phosphorylation assays with a myc epitope tagged version
of STE7 (STE7M). For these assays, we used the
catalytically inactive FUS3MArg42 which had been isolated
from E. coli as the STE7-specific substrate (Errede et al.,
1993). In contrast to the results with FUS3, disruption of
msgS did not result in increased amounts of STE7M-
catalyzed phosphorylation (Figure 7B, lanes 1 and 2). This
result excludes the possibility that msgS disruption has a
general affect on protein kinase activities. Instead, these
results raise the possibility that the MSG5 promotes cellular
adaptation to pheromone response by inhibiting FUS3.
MSG5 inactivates FUS3 in vitro
To test directly whether MSG5 is a protein phosphatase with
specificity for phosphorylated FUS3, we examined the effect
of MSG5 on the phosphorylation state and activity of
autophosphorylated FUS3. MSG5 and FUS3 were expressed
as GST fusion proteins in E. coli and these soluble proteins
were pdrified by affinity chromatography. The activity of
FUS3 was assayed by its ability to phosphorylate a truncated
FARI protein that was also produced and purified from
E. coli (Peter et al., 1993). Thus, all proteins for this test
were isolated from a background lacking potential con-
taminating kinases or phosphatases.
Autophosphorylation of bacterially produced FUS3 leads
predominantly to the modification of Tyrl82 and an
unidentified serine residue (Errede et al., 1993). When the
FUS3 autophosphorylation time was extended, we found
some phosphorylation also occurring at Thrl80 (Figure 8D).
The specific activity of such preparations also appeared to
be higher than that of the previously reported
autophosphorylation product (data not shown). We added
GST-MSG5 or GST-MSG5Ala3l9 to the high activity
form of autoactivated FUS3. After the indicated incubation
times, we then measured kinase activity with FARI protein
as substrate (Figure 8A, lanes 2-4 and 6-8). Treatment
of FUS3 with GST-MSG5 for increasing time resulted in
a progressive decrease in FUS3 phosphorylation and a
concomitant loss of kinase activity (Figure 8A, lanes 2-4).
Phosphoamino acid analysis of FUS3 indicated that the
abundance of all three phosphoamino acids is reduced by
the GST-MSG5 treatment (Figure 8B, compare lanes 13
and 14, panels D and E). The mutant form of the protein
phosphatase seems to retain some activity, although it is
much less pronounced compared with the wild-type product
(Figure 8A, lanes 1-8). Control experiments showed that
addition of GST polypeptide alone has no affect on the
phosphorylation state of FUS3 and that GST-MSG5 does
not directly dephosphorylate FAR1 (data not shown).
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MSG5 is a potential target for FUS3 although it remains to
be demonstrated that FUS3-dependent phosphorylation
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Fig. 8. Autophosphorylated FUS3 is dephosphorylated and inactivated
by MSG5. (A) Autoradiogram of kinase activity assays. In vitro
phosphorylated FUS3 was treated with GST-MSG5 (lanes 1-4 and
9-12) or GST-MSG5Ala3l9 (lanes 5-8). Incubation times were as
indicated. FARI was added (+) or not (-) after phosphatase
treatment. In lanes 9-12, phosphorylated FUS3 was heat denatured
before addition of GST-MSG5. The positions of GST-MSG5,
GST-FUS3, FUS3 and FARI are indicated. (B) shows an experiment
similar to panel A with FUS3 kinase activity before (lane 13) and after
GST-MSG5 treatment (lane 14). (C-E) Phosphoamino acid analysis
of autophosphorylated FUS3. (C) The positions of phospho-amino acid
standards are indicated. S, phosphoserine; T, phosphothreonine;
Y, phosphotyrosine. (D and E) Phosphorimager prints presenting the
phosphoamino acid analyses of FUS3 cut out from lanes 13 and 14,
respectively.
Together these results suggest that phosphatase activity of
MSG5 is necessary for the observed inactivation of FUS3.
Because FUS3 enzyme activity is completely inhibited while
some phosphorylated product remains, we cannot rule out
that steric mechanisms may also contribute to the inhibition.
For example, MSG5 may compete with FARI for the
enzyme active site.
Two additional observations are noteworthy. First, we
found that a native conformation of FUS3 is important for
its dephosphorylation by MSG5. When autophosphorylated
FUS3 was denatured by elevated temperature (5 min at
90°C) prior to the addition of GST-MSG5, there was no
decrease in FUS3 phosphorylation (Figure 8A, lanes 9-12).
This finding may also explain why in some experiments loss
of kinase activity preceded complete dephosphorylation of
FUS3 (for example, see Figure 8B, lanes 13 and 14). This
dependence on a native conformation is consistent with
MSG5 having a stringent substrate specificity. Second, in
addition to FAR1, the GST-MSG5 product also becomes
phosphorylated in these reactions. This effect is most
apparent using the GST-MSG5Ala3l9 substitution mutant
that does not inactivate FUS3 (Figure 8A, lanes 6-8). Thus,
Discussion
MSG5 has a role in adaptation to pheromone
Desensitization or adaptation is a property of most eukaryotic
signal transduction systems. Adaptive processes may function
at several levels within the signal transduction system,
including that of the receptor and downstream transducing
components. Often these processes require induction by the
stimulating agent and therefore constitute a specific response
to the signal. When yeast cells are exposed to prolonged
treatment with mating pheromone, they undergo an adaptive
response and resume growth (Moore, 1984). Thus
pheromone-dependent signal transduction in S.cerevisiae
provides an opportunity to investigate the interactions
between a signal transduction pathway and its adaptive
mechanisms.
We described the cloning and characterization of a novel
gene, MSG5, which accelerates recovery from pheromone
when overexpressed. For several reasons we believe that
MSG5 is part of an adaptive system as opposed to interfering
nonspecifically with the function of a signaling component.
First, loss of MSG5 function reduces the ability to adapt.
This phenotype is most apparent in connection with the
GPAJva15° allele, a mutation which normally allows cells to
recover faster from GI arrest. Second, transcription of the
gene is significantly induced after pheromone exposure. In
this regard MSG5 behaves similarly to SST2, another gene
which plays an essential role in recovery. MSG5, therefore,
satisfies the criteria that adaptive functions should be induced
as part of the overall response.
Origin of the adaptive signal
Uniike most other eukaryotic G protein-dependent signaling
systems, activation of the signal transduction system is not
carried out by the GCa subunit but by the Gfty dimer (for
review, see Marsh et al., 1991). However, there is evidence
suggesting that the dissociated Ga subunit encoded by GPAI
is important for adaptation (Miyajima et al., 1989; Stone
and Reed, 1990). A GPAlvam mutation which is analogous
to a constitutively activated mutation in ras (rasvall2) causes
accelerated recovery from pheromone. Since such a mutation
should increase the level of GTP bound Ga by decreasing
its intrinsic GTPase activity, it has been proposed that the
activated Ga stimulates an adaptive response that is
transduced separately from the mating signal generated by
GI3y (Miyajima et al., 1989). The discovery of the MSG5
gene has provided an opportunity to test this hypothesis
further. Our genetic analysis showed that the effect of the
GPAJVal50 allele is dependent on a functional MSG5 gene,
indicating that MSG5 is a potential target for a Ga-mediated
signal. GPA1 might induce a post-translational modification
of MSG5 that results in enhanced protein phosphatase
activity. Alternatively, GPA1 might be involved in the
transcriptional induction of MSG5.
Previously, the SGVJ product was identified as a potential
component of a Ga signaling pathway (Irie et al., 1991).
The SGVJ gene is essential for growth and encodes a kinase
with homology to CDC28. At the permissive temperature
sgvl-l mutants are supersensitive to pheromone and suppress
hyperadaptation in GPAJVa150 strains (Irie et al., 1991).
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Overexpression of MSG5, however, was unable to suppress
either the growth defect or supersensitivity of the sgvl
mutation (K.Irie and K.Matsumoto, unpublished obser-
vations). Assuming that both gene products function in the
same adaptive pathway, either MSG5 acts prior to SGV1
or its activity is dependent on SGV1.
How does MSG5 promote adaptation to pheromone?
The nucleotide sequence of the MSG5 gene strongly suggests
that it is a protein with PTPase activity. The most striking
similarity occurs in the region of a conserved cysteine, the
so-called HC motif, which is believed to form a critical part
of the active site of PTPases. Like other PTPases, bacterially
produced MSG5 protein was effective at dephosphorylating
p-nitrophenyl phosphate. This hydrolytic activity was
inhibited by orthovanadate. Furthermore, a mutation
changing codon Cys319 to Ala319 inactivated the enzyme
in vitro and abolished the ability of MSG5 in vivo to stimulate
the adaptation to pheromone. Thus, the MSG5 protein
displays the properties that are hallmarks of known PTPases.
Since FUS3 and KSS1 are the only known components
of the signaling pathway whose activity requires tyrosine
phosphorylation, they were prime candidates for targets of
MSG5. This prediction was confirmed by the demonstration
that a GST-MSG5 fusion protein dephosphorylates and
inactivates in vitro phosphorylated FUS3. Genetic analyses
are also consistent with the view that MSG5 antagonizes the
signal pathway at the position of FUS3. Epistatic interactions
imply that MSG5 functions between STEl 1 and STE12.
Furthermore, disruption of the MSG5 gene enhanced
FUS3-dependent kinase activity, whereas activity of STE7
remained unaffected. In preliminary experiments we found
that overexpression of MSG5 suppresses pheromone-induced
modification of FUS3 (A.Gartner, unpublished obser-
vations). Taken together these data suggest that FUS3 is at
least one of the physiological targets of MSG5. It is also
likely that dephosphorylation of FUS3 is the major
mechanism by which MSG5 desensitizes the G(3y-dependent
signal transduction system.
Our data suggest that MSG5 belongs to a novel subclass
of protein phosphatases whose substrates are MAP kinase
family members. Our observations showed that MSG5 is
highly discriminatory for its protein substrate, while
exhibiting multiple specificities for the modified amino acid.
Interestingly, a related phosphatase from mammalian cells
(CL100) has recently been described and also found to
dephosphorylate both the phosphotyrosine and phospho-
threonine of recombinant MAP kinase in vitro (Alessi et al.,
1993). Therefore, MAP kinases in general may be regulated
by a dual specificity threonine/tyrosine kinase and a dual
specificity threonine/tyrosine phosphatase. MSG5 will
become a very useful tool for dissecting the opposing
interactions which establish the level of MAP kinase activity.
Materials and methods
Yeast strains, media and genetic manipulation
The S.cerevisiae strains used in this study are listed in Table II. The
compositions of rich and synthetic media, supplemented with the appropriate
nutrients for plasmid maintenance, have been described previously (Miyajima
et al., 1989,Nomoto et al., 1990) Standard genetic procedures for yeast
were used (Sherman et al., 1986). Yeast transformations were carried out
by the alkali cation method (Ito et al., 1983).
Plasmids
The plasmid pG1606 is YCpNl (TRPJ as a selection marker) containing
the GPAlVaI5O gene (Miyajima et al., 1989). Plasmids pGS3 (Dolan and
Fields, 1990) and pG1501 (Miyajima et al., 1987) carry the STE12 and
GPAI structural genes, respectively, fused with the GALI promoter. These
are YCp-based plasmids with URA3 as a selection marker. The reporter
plasmid pUZ4 (TRPI as a selection marker in YCp-based plasmid) contains
three consensus binding sites for the transcriptional factor STE12 upstream
of the 3-galactosidase gene. Details of the construction and structure of this
plasmid are described by Cairns et al. (1992). YCpG33 is a centromere-
based URA3 plasmid containing the GAL] promoter (K.Sugimoto,
unpublished). Plasmids pNC318, pNC318-R220, pGA1903 and pGA1905
that were used for expression of STE7M, STE7MArg220, FUS3M and
FUS3MArg42, respectively, have been described (Gartner et al., 1992;
Zhou et al., 1993).
Cloning of MSG5 and gene disruptions
The MSG5 gene was cloned from the YEp213-based genomic DNA library
(provided by Akio Sugino) as the plasmid, YEpMSG5. This clone had an
insert of - 10 kb. Plasmid YEplacMSG5 was constructed by inserting 4
kb XbaI-Pstl fragment of YEpMSG5 into the vector YEplacl8l.
Two disruption mutations of the MSG5 gene were constructed as follows.
pSP contained the 2 kb HindU fragment of the MSG5 gene from YEpMSG5
cloned in pSP73 (Promega). To make the first disruption (msgS-I::LEU2),
pSPdis was created by inserting LEU2 into the StuI site ofMSG5 (Figure 2),
located 100 amino acids from the N-terminus of the putative protein. A
Pvull-SphI fragment of pSPdis containing the msgS-J::LEU2 construct was
used to transform a diploid strain 15D by selection for Leu+. Southern
analysis of genomic DNA from the resulting transformants was conducted
to confirm that transplacement had occurred at the MSG5 locus. The
transformant, heterozygous at the MSG5 locus (MSGGS/msg5-1::LEU2), was
designated DD1. To make the second MSG5 disruption (msgSA-2::LEU2),
the 1.4 kb EcoRI-PstI fragment of the MSG5 gene from YEpMSG5 was
cloned in pSP73. pSPdel was constructed by replacing the intemal StuI-Ball
fragment (Figure 2) with the LEU2 gene. A Bgfll fragment of pSPdel
containing the msgSA-2::LEU2 construct was used to transform 15D.
Southern hybridization and tetrad analysis confirmed that the transformed
diploids carried a single copy of the msg5A-2::LEU2 construction.
Sequencing of MSG5
Restriction endonuclease fragments of the 2 kb HindIm and 1.4 kb
EcoRI-Pstl were subcloned into pSP72 and pSP73. The sequences of both
strands were determined using Sequenase (US Biochemical Corp.). The
3'-region of MSG5 overlapped with an ORF residing 5'-side of the COXS
gene (Seraphin et al., 1985).
Construction of YCpGMSG5
The MSG5 coding sequence was amplified by a PCR using a 5' primer
(CTCGGATCCATGCAATTTCACTCAG) and a 3' primer (CTCGGA-
TCCTTAAGGAAGAAAC) both incorporating a BamHI site. PCR
amplification generated a 1.5 kb fragment that was digested with BamHI
and inserted into the BamHI site of YCpG33 to generate YCpGMSG5.
Expression of MSG5 in bacteria
In order to express MSG5 in E. coli, the BamHI fragment of YCpGMSG5
was subcloned into the BamHI site of pGEX-KG (Guan and Dixon, 1991)
to produce pGEX-MSG5. JM109 Ecoli transformed with PGEX-MSG5
were grown in L-broth at 37'C to an optical density of 0.5 and induced
for an additional 3 h in the presence of 1 mM IPTG. GST-MSG5 fusion
protein was purified as previously described (Millar et al., 1991).
Site-directed mutagenesis
A mutation of MSG5 (MSG5A1a3I9) containing alanine instead of cysteine
at a position 319 was prepared as follows. The first PCR was performed
with SP6 primer (Takara) as the 5' primer and the 3' primer GATCTT-
GATACTCCACACTGCGCATGTACGAGTATlTrCTTG containing an
FspI site. The second PCR was performed with the 5' primer GGCAAG-
AAAATACTCGTACATGCGCAGTGTGGACTATCAAGATC containing
an FspI site and T7 primer (Stratagene) as the 3' primer. Both PCRs used
pSP2 as the template. The first PCR fragment was digested with EcoRI
and FspI and the second PCR fragment was digested with FspI and PstI.
These two digested fragments were ligated into EcoRI -PstI site of pSP73
to obtain pSPmut. The DNA sequence between SphIand PstI sites on pSPmut
was confirmed. A 0.9 kb SphI- oIfragment ofpGEX-MSG5 was replaced
with the DNA fragment from pSPmut containing the mutation to produce
pGEX-MSG5Ala3l9. YCpGMSG5Ala319 was constructed by inserting the
BamHI-XhoI fragment of pGEX-MSG5AIa3l9 into the BamHI-SalI site
of YCpG33.
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Northern bloffing
Northern blot analysis was performed as described previously (Wittenberg
et al., 1990). The DNA fragments used as probes are as follows: MSG5,
the 1.4 kb EcoRI-PstI fragment from the coding region of MSG5; FUS1,
the 1.4 kb EcoRI fragment from plasmid pBS231 (Trueheart et al., 1987);
LEU2, the 1.42 kb ClaI-XhoI fragment from plasmid YEpl3.
Cell cycle synchronization by mating pheromone
Synchronization by mating pheromone was accomplished as described
previously (Wittenberg et al., 1990).
Pheromone sensitivity assays
A halo bioassay was used to measure the sensitivity of cells to a-factor-
induced growth arrest. After growth to mid-log phase, - 105 cells were
diluted into 8 ml of soft agar and spread onto plates. Disks of chromatography
paper (6 mm diameter; Whatman) were placed on the nascent lawn. Different
concentrations of synthetic a-factor (Sigma) were dotted onto the disks in
4 Al aliquots.
,3-galactosidase assays
(3-galactosidase assays were performed as described previously (Miyajima
et al., 1989).
Phosphatase assays
Dephosphorylation of pNPP was performed as described previously (Millar
etal., 1991).
In vitro FUS3 and STE7 kinase assays
The FARI N-terminal fragment used as the specific substrate for FUS3
kinase assays was expressed in E. coli and isolated as previously described
(Peter et al., 1993). The FUS3MArg42 protein used as the specific substrate
for STE7 kinase assays was expressed in E. coli and isolated as previously
described (Errede et al., 1993). Conditions for immune complex isolation
of FUS3M and STE7M and for phosphorylation assays were as previously
described (Errede et al., 1993), with the exception that cold ATP was
included in the FUS3M kinase reaction at a concentration of 100 AM.
Protein phosphatase assays
Bacterially produced GST-FUS3 product was purified and cleaved to obtain
FUS3 as described by Errede et al. (1993). The 251 amino acid N-terminal
fragment of FARI was produced as described by Peter et al. (1993).
GST-MSG5 was isolated as described above and was stored after elution
from glutathione beads in 50% (vol) glycerol, 10 mM DTT, 10 mM MgC12
and 1 mM MnCl2. FUS3 was phosphorylated at 30°C for 3.5 h after
combining 67 1l reaction buffer (25 mM MOPS pH 7.2, 15 mM MgCl2,
5 mM EGTA, 10 mM DTT and 1 mM MnCl2), 10 A1 1 mM ATP and
5.5 t1 [-y-32P]ATP (55 ,uCi), 15 11 FUS3 (3 Ag) and 5.2 1 250 mM MOPS
pH 7.2. After 3.5 h, 90 A1 reaction buffer was added and the mixture was
divided into 35 IA aliquots. Six microlitres of GST-MSG5 or
GST-MGS5ma3l9 (-60 ng) were added to each sample. For studies with
denatured FUS3, the reaction mix was heated to 90°C for 5 min and cooled
before adding phosphatase. After 0, 5, 10 and 25 min of incubation at 30°C
the reactions were either stopped immediately by adding 15 dl of SDS sample
buffer or after 1 A1 of FARI (1 jig) was added for an additional 5 min.
Proteins were separated by SDS-PAGE and visualized by autoradiography.
Labeled FUS3 was cut out of the dried gel and subjected to phosphoamino
acid analysis as described (Cooper et al., 1983).
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